A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...
The CDC estimates 2.2 million Americans could benefit from HIV prevention drugs, but just over a quarter of that group have ...
Brazil's Health Regulatory Agency (Anvisa) approved on Monday the use of the drug Sunlenca (lenacapavir) for HIV-1 prevention ...
The Star Worldwide (English) on MSN
Kenya to begin once-in-six-months HIV prevention injection
Kenya will this year begin rolling out a new long-acting injectable HIV prevention drug, Lenacapavir, positioning the country ...
The Kenya Times on MSN
Kenya to introduce long-acting HIV prevention drug in landmark move
Kenya has taken a major step towards expanding HIV prevention options after the Ministry of Health formally recommended the ...
Ryan Haumschild, PharmD, MS, MBA: Hello and welcome to this AJMC® Peer Exchange program titled, “From Evidence to Implementation: Clarifications Around the US Preventive Services Task Force ...
HIV pre-exposure prophylaxis (PrEP) is an effective and safe intervention for individuals with behaviors that are considered high risk for acquiring HIV infection. Despite the success of this ...
The New Times on MSN
Six-month HIV prevention injection set for rollout by year-end
The government plans to introduce lenacapavir, a long-acting injectable drug for HIV prevention, in the last quarter of the ...
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced a pause in enrollment for the IMPOWER 22 (MK-8591-022) and IMPOWER 24 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback